Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Human leucocyte antigen-G (HLA-G) and its murine functional homolog Qa2 in the Trypanosoma cruzi Infection.

Dias FC, Mendes-Junior CT, Silva MC, Tristão FS, Dellalibera-Joviliano R, Moreau P, Soares EG, Menezes JG, Schmidt A, Dantas RO, Marin-Neto JA, Silva JS, Donadi EA.

Mediators Inflamm. 2015;2015:595829. doi: 10.1155/2015/595829. Epub 2015 Jan 20.

2.

Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients.

Egui A, Thomas MC, Morell M, Marañón C, Carrilero B, Segovia M, Puerta CJ, Pinazo MJ, Rosas F, Gascón J, López MC.

Mol Immunol. 2012 Oct;52(3-4):289-98. doi: 10.1016/j.molimm.2012.05.021. Epub 2012 Jun 29.

PMID:
22750229
3.

Analysis of the dynamics of infiltrating CD4(+) T cell subsets in the heart during experimental Trypanosoma cruzi infection.

Sanoja C, Carbajosa S, Fresno M, Gironès N.

PLoS One. 2013 Jun 11;8(6):e65820. doi: 10.1371/journal.pone.0065820. Print 2013.

4.

Trypanosoma cruzi: acute infection affects expression of alpha-2-macroglobulin and A2MR/LRP receptor differently in C3H and C57BL/6 mice.

Soeiro Mde N, Paiva MM, Waghabi MC, Meirelles Mde N, Lorent K, Henriques-Pons A, Coutinho CM, Van Leuven F, Araújo-Jorge TC.

Exp Parasitol. 2000 Oct;96(2):97-107.

PMID:
11052868
5.

Cytokine responses in Trypanosoma cruzi-infected children in Paraguay.

Samudio M, Montenegro-James S, Cabral M, Martinez J, Rojas de Arias A, James MA.

Am J Trop Med Hyg. 1998 Jan;58(1):119-21.

PMID:
9452302
6.
7.
8.

Timing of expression of inflammatory mediators in skeletal muscles from mice acutely infected with the RA strain of Trypanosoma cruzi.

Cutrullis RA, Postan M, Petray PB, Corral RS.

Pathobiology. 2009;76(4):170-80. doi: 10.1159/000218333. Epub 2009 Jun 29.

9.

Identification of HLA-A∗02:01-restricted CTL epitopes in Trypanosoma cruzi heat shock protein-70 recognized by Chagas disease patients.

Marañón C, Egui A, Carrilero B, Thomas MC, Pinazo MJ, Gascón J, Segovia M, López MC.

Microbes Infect. 2011 Nov;13(12-13):1025-32. doi: 10.1016/j.micinf.2011.05.010. Epub 2011 Jun 12.

PMID:
21704723
10.

Mast Cells and Serotonin Synthesis Modulate Chagas Disease in the Colon: Clinical and Experimental Evidence.

Kannen V, Sakita JY, Carneiro ZA, Bader M, Alenina N, Teixeira RR, de Oliveira EC, Brunaldi MO, Gasparotto B, Sartori DC, Fernandes CR, Silva JS, Andrade MV, Silva WA Jr, Uyemura SA, Garcia SB.

Dig Dis Sci. 2018 Jun;63(6):1473-1484. doi: 10.1007/s10620-018-5015-6. Epub 2018 Mar 22.

PMID:
29569002
11.

Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease.

Pereira IR, Vilar-Pereira G, Silva AA, Moreira OC, Britto C, Sarmento ED, Lannes-Vieira J.

Mediators Inflamm. 2014;2014:798078. doi: 10.1155/2014/798078. Epub 2014 Jul 22.

12.

Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.

Silverio JC, de-Oliveira-Pinto LM, da Silva AA, de Oliveira GM, Lannes-Vieira J.

Int J Exp Pathol. 2010 Feb;91(1):72-86. doi: 10.1111/j.1365-2613.2009.00670.x. Epub 2009 Oct 28.

13.

[TH1 response in the experimental infection with Trypanosoma cruzi].

Cardoni RL, Antúnez MI, Abrami AA.

Medicina (B Aires). 1999;59 Suppl 2:84-90. Spanish.

PMID:
10668248
14.

Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.

Bhatia V, Garg NJ.

Clin Vaccine Immunol. 2008 Aug;15(8):1158-64. doi: 10.1128/CVI.00144-08. Epub 2008 Jun 11.

15.

Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression.

Gupta S, Smith C, Auclair S, Delgadillo Ade J, Garg NJ.

PLoS One. 2015 Jun 15;10(6):e0130562. doi: 10.1371/journal.pone.0130562. eCollection 2015.

16.

Programmed death ligand 2 regulates arginase induction and modifies Trypanosoma cruzi survival in macrophages during murine experimental infection.

Dulgerian LR, Garrido VV, Stempin CC, Cerbán FM.

Immunology. 2011 May;133(1):29-40. doi: 10.1111/j.1365-2567.2011.03406.x. Epub 2011 Feb 8.

17.

CTLA-4 regulates the murine immune response to Trypanosoma cruzi infection.

Graefe SE, Jacobs T, Wächter U, Bröker BM, Fleischer B.

Parasite Immunol. 2004 Jan;26(1):19-28.

18.

Adipose Tissue-Derived Mesenchymal Stromal Cells Protect Mice Infected with Trypanosoma cruzi from Cardiac Damage through Modulation of Anti-parasite Immunity.

Mello DB, Ramos IP, Mesquita FC, Brasil GV, Rocha NN, Takiya CM, Lima AP, Campos de Carvalho AC, Goldenberg RS, Carvalho AB.

PLoS Negl Trop Dis. 2015 Aug 6;9(8):e0003945. doi: 10.1371/journal.pntd.0003945. eCollection 2015.

19.

Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease.

Argüello RJ, Albareda MC, Alvarez MG, Bertocchi G, Armenti AH, Vigliano C, Meckert PC, Tarleton RL, Laucella SA.

PLoS One. 2012;7(5):e35966. doi: 10.1371/journal.pone.0035966. Epub 2012 May 4.

20.

Trypanosoma cruzi: role of host genetic background in the differential tissue distribution of parasite clonal populations.

Andrade LO, Machado CR, Chiari E, Pena SD, Macedo AM.

Exp Parasitol. 2002 Apr;100(4):269-75.

PMID:
12128054

Supplemental Content

Support Center